Academic Credentials
  • M.P.H., Epidemiology, Brown University, 2014
  • B.A., English and Spanish Literature, Skidmore College, 2005
Professional Honors
  • Emerging Leader Award, International Society for Pharmacoepidemiology, 2025
Professional Affiliations
  • Gerontology Society of America
  • International Society for Pharmacoepidemiology

Catherine Rogers Murray, M.P.H., is a managing scientist in Exponent's Health Sciences practice with over a decade of experience in pharmacoepidemiology, health data infrastructure, and medical product safety. She advises pharmaceutical manufacturers, regulatory bodies, and legal teams on medical product safety surveillance, real-world evidence studies, clinical trials, and stakeholder engagement, with particular expertise in large-scale distributed data networks.

Health Data Infrastructure

Ms. Rogers Murray brings deep operational expertise in building and managing the data systems that power large-scale pharmacoepidemiologic research. Her work on the FDA's Sentinel Initiative — a national active surveillance network spanning hundreds of millions of patient records across multiple health care data partners — gave her firsthand experience designing data governance frameworks, standardizing distributed data models, and implementing transparency protocols that meet the highest standards of scientific rigor. She helps clients assess the fitness of data sources (administrative claims databases, electronic medical records, registries, surveys, etc.) for specific research questions, and she advises on data quality, completeness, and analytic reproducibility before a study begins.

Pharmacoepidemiology & Drug Safety

Ms. Rogers Murray designs and conducts pharmacoepidemiologic studies including cohort, case-control, and self-controlled designs; confounding control methods including propensity score approaches; and the application of causal inference frameworks such as target trial emulation. She advises pharmaceutical manufacturers, insurers, and regulatory agencies on interpreting safety signals, characterizing benefit-risk profiles, and communicating findings to non-technical audiences. When litigation arises over medical product safety, Ms. Rogers Murray provides consulting support to legal teams evaluating the totality of epidemiologic evidence, study methodology, and regulatory submissions.

Scientific Communications

Translating complex epidemiologic findings into clear, credible, and actionable communications is a core strength Ms. Rogers Murray brings to every engagement. She has developed communication strategies for regulatory programs, academic consortia, and public health initiatives and has written for audiences ranging from FDA decision-makers and medical product manufacturers to academic researchers and the general public. Her background includes professional copy editing, marketing communications, and publication support, giving her an unusually broad range of tools for making technical science accessible without sacrificing accuracy.

Stakeholder Consensus Building

One of Ms. Rogers Murray's most distinctive capabilities is her ability to bring together diverse, sometimes competing stakeholders and build the shared understanding needed to move complex programs forward. She has served as a facilitative bridge across these communities throughout her career, designing and leading engagement processes that surface differing perspectives, establish common ground, and produce durable agreements. This skill is particularly valuable in multi-site research collaborations, regulatory negotiations, and public health initiatives where no single party controls the outcome.